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Abstract
Background: The c-myb proto-oncogene is the founding member of a family of transcription factors involved
principally in haematopoiesis, in diverse organisms, from zebrafish to mammals. Its deregulation has been
implicated in human leukaemogenesis and other cancers. The expression of c-myb is tightly regulated by post-
transcriptional mechanisms involving microRNAs. MicroRNAs are small, highly conserved non-coding RNAs that
inhibit translation and decrease mRNA stability by binding to regulatory motifs mostly located in the 3’UTR of
target mRNAs conserved throughout evolution. MYB is an evolutionarily conserved miR-150 target experimentally
validated in mice, humans and zebrafish. However, the functional miR-150 sites of humans and mice are
orthologous, whereas that of zebrafish is different.
Results: We identified the avian mature miRNA-150-5P, Gallus gallus gga-miR-150 from chicken leukocyte small-
RNA libraries and showed that, as expected, the gga-miR-150 sequence was highly conserved, including the seed
region sequence present in the other miR-150 sequences listed in miRBase. Reporter assays showed that gga-miR-
150 acted on the avian MYB 3’UTR and identified the avian MYB target site involved in gga-miR-150 binding. A
comparative in silico analysis of the miR-150 target sites of MYB 3’UTRs from different species led to the
identification of a single set of putative target sites in amphibians and zebrafish, whereas two sets of putative
target sites were identified in chicken and mammals. However, only the target site present in the chicken MYB
3’UTR that was identical to that in zebrafish was functional, despite the additional presence of mammalian target
sites in chicken. This specific miR-150 site usage was not cell-type specific and persisted when the chicken c-myb
3’UTR was used in the cell system to identify mammalian target sites, showing that this miR-150 target site usage
was intrinsic to the chicken c-myb 3’UTR.
Conclusion: Our study of the avian MYB/gga-miR-150 interaction shows a conservation of miR-150 target site
functionality between chicken and zebrafish that does not extend to mammals.
Background
c-myb was originally identified as the chicken cell homo-
logue of the v-myb oncogenes found in two strains of
avian leukosis virus [1,2]. These avian v-myb oncogenes
induce myeloid and erythroid forms of leukaemia in
chickens and the activation of the c-myb promoter by
the insertion of avian and murine retroviruses has also
been implicated in diverse forms of leukaemia [3,4]. A
role for MYB in human leukaemogenesis was initially
suspected following the demonstration of MYB overpro-
duction in cells from patients with leukaemia. This role
has recently been confirmed by the detection of duplica-
tions and translocations affecting the c-myb locus, parti-
cularly in acute and chronic myeloid leukaemia and in
acute T-cell lymphoblastic leukaemia [5,6]. MYB dereg-
ulation is also associated with colorectal cancers [7,8],
carcinomas [9] and breast cancers expressing oestrogen
receptor-alpha [10], in which MYB has been implicated
in prolactin-induced signalling pathways [11].
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for haematopoietic lineage specification, T- and B-lym-
phocyte differentiation, colonic mucosal crypt regenera-
tion and brain neurogenesis, on the basis of the abnormal
phenotypes observed in mouse myb mutants [12,13]. In
zebrafish, MYB has also been shown to be essential for
haematopoiesis [14,15] and the silencing of c-myb in zeb-
rafish embryos also leads to abnormal phenotypes, with
effects on eye tissue formation in particular [16].
c-myb is the founding member of a family of genes
encoding transcription factors with a DNA-binding
domain consisting of three regions: R1, R2 and R3 [12].
Vertebrate genomes contain two other closely related
g e n e sf r o mt h i sf a m i l y[ 1 7 ] :MYBL1 (also known as A-
myb), which is expressed in a restricted panel of tissues,
and Mybl2 (also known as B-myb), which is ubiquitously
expressed. The products of these genes regulate the
expression of genes involved in the control of cell prolif-
eration and differentiation [18-20]. In plants, the R2R3
MYBs constitute a large family of transcription factors
involved in the regulation of plant-specific developmen-
tal and physiological processes [21].
MYB generally acts as a transcriptional activator, bind-
ing to the MYB binding site on DNA [22] and recruiting
the CBP/p300 coactivator proteins [23,24], thereby
increasing the level of transcription of MYB targets. The
oncogenic properties of MYB result from the overex-
pression or inappropiate activation of c-myb [13].
The level of c-myb expression is critical and is regu-
lated by a number of mechanisms. At the transcriptional
level, the c-myb promoter may be transactivated by a
large number of proteins, including MYB itself, and
attenuation sequences identified in the first intron of
myb also regulate Myb elongation [13,25]. No particular
pattern of cell specificity has been clearly demonstrated
for transcriptional regulation processes, whereas tight
control over the levels of mature MYB mRNA is
restricted to tissue compartments with a high turnover.
M Y Bm R N Aa n dM Y Bp r o t e i nh a v eav e r ys h o r th a l f -
life [13]. They are present in large amounts in haemato-
poietic progenitor cells but are absent from terminally
differentiated cells, suggesting that rapid changes occur
[26]. An absolute requirement for the fine-tuning of c-
myb expression was recently highlighted by the demon-
stration of a compromising effect of decreases in c-myb
gene activity on murine haematopoietic stem cells, lead-
ing to a myeloproliferative disorder involving stem cells
with novel characteristics [27].
The post-transcriptional mechanisms regulating MYB
levels involve microRNAs (miRNAs). miRNAs constitute
a class of highly conserved small (21-24 nucleotides)
non-coding RNAs found in plants and animals [28]. In
animals, mature miRNAs generated by processing from
the stem loop pre-miRNA are incorporated into the
silencing complex (for a review see [28]), which med-
iates post-transcriptional repression by binding to
mRNA molecules, causing a decrease in the rate of
translation or stability of the target mRNA [28-32].
Metazoan miRNA target recognition is based on Wat-
son-Crick pairing of the 5’ region of the miRNA, mostly
via nucleotides 2 to 8 – known as the miRNA seed – to
sites generally located within the 3’-untranslated region
(UTR) of the target mRNA. Several hundreds of miR-
NAs with highly conserved sequences have been identi-
fied in diverse vertebrate species, from fish to humans
[28]. Moreover, the lengths and sequences of the 3’
UTRs from mammals and birds are sufficiently similar
for alignments to be generated [33]. Prediction algo-
rithms (reviewed in [29]) based on base-pairing between
the miRNA seed and mRNA sequences have identified
potential miRNA target sites in thousands of human
genes [34,35]. A comparative analysis of several mam-
malian genomes suggested that miRNA target sites were
conserved regulatory motifs in mammals [33]. A pio-
neering comparative analysis of mammalian and fish
miRNA targets yielded 240 orthologous miRNA target
genes conserved between these two groups [34].
It has been predicted that miRNAs may regulate the
production of proteins from as many as 10% to 30% of
the genes present in the human genome [35]. There is
evidence to suggest that miRNA function is critical for
normal cellular development and homeostasis. The pro-
duction of miR-150 in mature B and T cells has been
shown to block early B-cell development, and its ectopic
production in haematopoietic stem cells and progenitor
cells has been shown to result in significantly lower
than normal numbers of mature B cells [36]. Moreover,
miR-150 controls B-cell differentiation by targeting mur-
ine MYB in a dose-dependent manner [37]. By targeting
MYB, miR-150 also drives the differentiation of murine
megakaryocyte-erythrocyte progenitors into megakaryo-
cytes, indicating a key role for miR-150 in controlling
lineage commitment [38]. Thrombopoietin also induces
megakaryopoiesis by downregulating MYB expression
through the effects of miR-150 [39]. Overall, in haema-
topoietic lineages and the B-cell subsets of tonsil tissues,
miR-150 and MYB display opposite patterns of expres-
sion [40]. Opposite patterns of miR-150 and MYB
expression are also observed in immortalised cell lines,
in which no miR-150 is detected [41].
Like most vertebrate mRNAs [35], MYB mRNAs are
conserved targets of microRNAs. Functional miR-150
target sites have been validated in human, murine and
zebrafish MYB 3’UTRs [16,37] and orthologous func-
tional target sites of miR-150 have been identified in
mammals, but are not conserved in zebrafish.
We sought to increase knowledge about miR-150/
MYB interactions during the course of evolution, by
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attempts at extensive or deep sequencing [42-47] have
generated a list of more than a hundred chicken miR-
NAs in miRbase, but only a few chicken targets have
been validated [48-50]. The chicken, an amniote that
has evolved separately from mammals for about 310
million years, has provided unique data on vertebrate
evolution [51]. The evolutionary distance between
chicken and mammals may eventually facilitate studies
of the target site adaptation of mammalian miRNAs.
We used a reporter assay to identify the functional tar-
gets of miR-150 in the avian MYB 3’UTR and per-
formed a comparative in silico analysis of predicted and
experimentally validated functional target sequences in
the vertebrate MYB 3’UTR (frog, fishes, chicken, mam-
mals). Our findings show that the number of putative
miR-150 target sites has increased during evolution,
with chicken and mammals displaying an additional set
of target sites, but with only one of the sites in chicken
being functional, that identical to the functional site in
zebrafish. The avian miR-150 bound to the same target
sites in chicken cells and in the human cell line used to
identify mammalian miR-150 target sites, demonstrating
the specificity of this pattern of binding to the avian
MYB 3’UTR.
Results and Discussion
Cloning of mature avian gga-miR-150
We cloned avian mature miRNA-150-5P (Gallus gallus,
gga-miR-150) from small-RNA libraries derived from
spleen or peripheral blood leukocytes before and at
advanced stages of Marek’sd i s e a s ev i r u s( M D V ) -
induced lymphomagenesis in chickens (69 reads). By
contrast, gga-miR-150 was not detected in libraries
derived from chicken immortalised lymphoid cell lines
[52,53]; [our unpublished data]. The expression pattern
of the avian gga-miR-150 is similar to that of the
human hsa-miR-150, which is expressed in normal
human haematopoietic cell lineages but not in immorta-
lised cell lines [16,41]. The sequences of miRNAs seem
to have been conserved during evolution, because the
mature gga-miR-150 cloned from our libraries and the
recently released sequence [54]http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GPL6541 contain the seed
region (nt2 to nt8) sequence (CUCCCAA) identified in
the other twelve miR-150 sequences listed in miRBase
[55,56]http://microrna.sanger.ac.uk (Fig. 1). All mature
miR-150 sequences begin with a uracil (U) residue and
only four positions have been found to harbour changes
(Fig. 1). The mature gga-miR-150 sequence differed
from its human and murine counterparts by one resi-
due, and from the zebrafish sequence by two residues
(Fig. 1).
Chicken gga-miR-150 targets avian MYB
We investigated the targeting of avian MYB by gga-miR-
150 in luciferase reporter assays on cell cultures. The
sequence of the precursor pri-miRNA gga-miR-150 is
not present in the released sequence of the Gallus gallus
genome [57]http://www.ncbi.nlm.nih.gov/projects/gen-
ome/guide/chicken/ and we were unable to identify pri-
miRNA gga-miR-150 on the basis of synteny with
human and zebrafish. We therefore constructed a syn-
thetic avian pre-miR-150, based on a comparison of var-
ious mammalian pre-miR-150 sequences and stem loop
structures (Additional file 1). The synthetic avian pre-
miR-150 amplicon obtained by PCR with appropriate
primers (Additional file 2) was introduced into a
pcDNA3 vector (pmiR-150). We used a miR-150 mutant
plasmid (pmiR-150mut) as a control, with the deletion
of one C residue within the miR seed sequence (Fig. 1),
to prevent pairing between gga-miR-150 and putative
targets in the avian MYB 3’UTR. We assessed the func-
tionality of gga-miR-150, by establishing stable lymphoid
chicken MDV cell lines ectopically producing gga-miR-
150 or mutated gga-miR-150. The chicken MDV cell
lines MSB-1 [58] and PA9 [59] were transfected with
pmiR-150, pmiR-150mut or pcDNA vectors. MDV cells
ectopically producing gga-miR-150 (MDVT-150) or
mutated gga-miR-150 (MDVT-150mut) and control
pcDNA-transfected cells (MDVT) were then isolated by
selection on neomycin. Northern blots showed the ecto-
pic production of a mature gga-miR-150 of the same
size by MDVT-150 cells and spleen cells, whereas a
slightly smaller mature mutated gga-miR-150 was
detected in MDVT-150mut cells (Fig. 2A). These find-
ings are consistent with the deletion of one nucleotide
from the mature mutated gga-miR-150, confirming the
successful transcription and maturation of synthetic
avian pre-miR-150 from vectors with pol II promoters
[60].
We investigated the targeting of avian MYB by gga-miR-
150, by inserting the 3’UTR fragment of the chicken
MYB cDNA into a pRL-TK vector downstream from
the Renilla luciferase reporter gene. The various MDVT
cells were cotransfected with the MYB WT pRL-TK
vector and the internal control pcDNAMluc vector
encoding firefly luciferase, by electroporation, and dual
luciferase assays were performed. We normalised lucifer-
ase activity, taking the value for MDVT-150mut cells as
100%, as mutated gga-miR-150 did not repress activity
in MDVT-150mut cells. The activity of the MYB WT
reporter was specifically repressed by gga-miR-150 in
PA9 and MSB-1T-150 cells (by up to about 80%) (Fig.
2B). We also transiently cotransfected avian DF1 fibro-
blasts with pmiR-150, pmiR-150mut or pcDNA plasmids
and the MYB WT pRL-TK vector. Reporter assays in
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MYB WT reporter activity to about 60% (Fig. 3). Thus,
in chickens, as in humans [16], the repression of MYB
WT reporter activity by miR-150 does not seem to be
cell type-specific and gga-miR-150, like its orthologues
in humans, mice and zebrafish [16,37], specifically tar-
gets the 3’UTR of MYB.
gga-miR-150 uses a target site orthologous to that of
zebrafish
We identified four putative miR-150 target sites in the
chicken MYB 3’UTR (Fig. 3A), all matching the criteria
for miRNA target recognition and target site sequence
context within the 3’UTR [35,61-63]. Sites s1 and s3,
located 85-106 nt and 830-850 nt downstream from the
stop codon, respectively, were 7-mer-A1 sites containing
the seed sequence with an additional A residue in target
position 1 (Fig. 3A). Such sites have been shown to be
functional in various systems [63]. Sites s2 and s4,
located 123-142 nt and 918-938 nt downstream from
the stop codon, respectively, were 9-mer-A1 and 8-mer-
A1 sites (Fig. 3A). These sites are probably at least as
effective as the 8-mer sites shown to be functional in
various systems, from worms to mammals [29]. Addi-
tional pairing to the middle and the 3’ end of gga-miR-
150 was also observed, extending from one individual
match to seven consecutive matches, for sites s4 and s2,
respectively (Fig. 3A). We generated MYB mutant pRL-
TK vectors, each containing only one of the four
mutated target sites (mt1 to mt4), and one mutant con-
taining all four mutated target sites (mt1234). The var-
ious MYB mutant pRL-TK vectors were used to
transfect either avian DF1 fibroblasts [64] or human
293FT cells, as described above. Avian DF-1 fibroblasts
were used to assess gga-miR-150 site usage in the
homologous system. We used human 293FT cells, origi-
nating from the HEK-293T cell line, as a reference het-
erologous system, because the HEK-293T cell line has
been used to identify miR-150 target sites in mice,
humans and zebrafish [16,37]. We then carried out
reporter assays. The same reporter activity patterns were
observed in both systems, demonstrating that the
observed pattern of target site usage resulted from
intrinsic characteristics of chicken c-myb 3’UTR. We
f o u n dt h a tp m i R - 1 5 0d i dn o tr e p r e s st h ea c t i v i t yo ft h e
MYB mt1234 reporter or the MYB mt2 construct
whereas the activities of MYB mt1, mt3 and mt4 were
significantly repressed (by about 40 to 60%) (Fig. 3B).
Thus, gga-miR-150 specifically targets the 3’UTR of
avian MYB, acting principally through target site s2 in
Figure 1 Comparison of the sequence of avian gga-miR-150 with all miR-150 sequences from the miRBase. The human sequence was
taken as the reference sequence. The seed sequence is shown in red and changes are shown in green, underlined. Sequences were predicted
on the basis of sequence similarity or experimentally validated. Hsa, Homo sapiens; ptr, Pan troglodytes; mml, Macaca mulatta; mmu, Mus
musculus; rno, Rattus norvegicus; cfa, Canis familiaris; eca, equus caballus; bta, Bos taurus; mdo, monodelphis domestica; oan, Ornithorhynchus
anatinus; gga, Gallus gallus; dre, Danio rerio; xtr, Xenopus tropicalis. The sequence of the mutated gga-miR-150 (gga-miR-150mut) that we
constructed is shown.
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Page 4 of 11Figure 2 gga-miR-150 ectopically produced in stable lymphoid chicken PA9 and MSB-1 cells represses the avian MYB reporter. (A)
gga-miR-150 and gga-miR-150mut detected by northern blotting. Positive control: spleen leukocytes from a 4-week-old chicken. Northern blots
were performed with a
32P-5’ end-labelled DNA oligonucleotide probe complementary to the miRNA. (B) The MYB reporter was repressed in
PA9 or MSB-1 cells producing gga-miR-150. PA9 and MSB-1 cells were electroporated with 40 μg of avian MYB WT pRL-TK reporter and 500 ng
of the normalising plasmid containing the firefly luciferase gene, pcDNAMLuc. Luciferase activity was determined 24 hours after transfection.
Renilla luciferase activity was normalised with respect to firefly luciferase activity and luciferase activity in PA9 and MSB-1 cells producing gga-
miR-150mut was set at 100%. The data from one experiment representative of the three carried out are shown, with all three assays generating
essentially identical results (* significant repression, P < 0.05, Student’s t-test comparisons with PA9T or MSB-1T150mut).
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of target site s2 by gga-miR-150 therefore seems to
result from the intrinsic properties of the chicken MYB
3’UTR. The observed functionality of avian MYB target
site 2 is consistent with previous observations showing
that higher levels of 3’ base pairing render the site more
effective [61,62]. Although both target sites, s2 and s4,
d i s p l a ys t r o n gb a s ep a i r i n gw i t ht h eg g a - m i R - 1 5 0s e e d
sequence, only site s2, which also displays base pairing
for 7 nt at its 3’ end, is a functional target for gga-miR-
150 (Fig. 3A and 3B). This observation highlights the
importance of extended 3’ pairing for gga-miR-150.
Figure 3 The avian MYB 3’UTR contains a functional miR-150 target site. (A) Predicted binding structures between gga-miR-150 and the
four putative target sites (s1, s2, s3, s4) or their mutated counterparts (mt1, mt2, mt3, mt4) are shown. Numbers correspond to the position of
the site in the avian MYB 3’UTR (nt1 = first nt downstream from the stop codon); nt in bold are involved in nt pairing. (B) gga-miR-150
repressed MYB reporters in chicken DF-1 cells or human 293FT cells through one specific target site. DF-1 or 293FT cells were cotransfected with
100 ng of reporter, 300 ng of effector and 1.25 ng of normalising pcDNAMLuc plasmid. Luciferase assays were performed as in Fig. 2 and
luciferase activity following transfection with pmiR-150mut was set at 100%. Reporter plasmids: MYB WT reporter, MYB mt1, mt2, mt3, mt4,
mt1234 reporters. Effector plasmids: pmiR-150, pmiR-150mut. The data presented are means ± SDs of three independent experiments
(* significant repression, P < 0.05, Student’s t-test comparisons with pmiR-150mut controls).
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by miR-150 has been conserved throughout evolution,
as it is observed in mice, humans and zebrafish [16,37].
However, analysis of the targeting of MYB 3’ UTR by
miR-150 in the various species in which functional tar-
get sites have been validated has shown that miR-150
targeting seems to be dependent on the use of different
target sites. Synergy between two target sites located in
the last third of the 3’ UTR of the human and murine
c-myb genes is required for the regulation of these
genes [16,37], whereas only one target site about 120 nt
downstream from the c-myb stop codon is functional in
chicken and zebrafish (Fig. 4). Detailed analysis of the
sequence of the 3’ UTR of MYB from various species
showed that the short 3’UTRs of MYB (frog and
medaka) and the 3’ UTR of MYB orthologs of zebrafish
contained two miR-150 target sites close together in the
proximal region, less than 150 nt downstream from the
stop codon, and that the large 3’UTR of chickens and
mammals contained two additional miR-150 target sites
located close together, between 800 and 970 nt from
the stop codon (Fig. 4A). However, not all these sites
appeared functional and most non-functional ones were
mutated, with the exception of site 4 in chicken (Fig.
4B). Site 2, for example, which is functional in chicken
and zebrafish and has two conserved mutations in
mammals, is not functional in mouse [37] (Fig. 4B).
Surprisingly, despite the presence of sequence changes
in site 2 rendering it non-functional in mammals (Fig.
4B), the 3’ end sequences of this site identified in
Figure 4 Putative miR-150 target sites in MYB 3’UTR conserved through evolution. The chicken MYB 3’UTR contains the same four putative
miR-150 target sites as observed in mammals, but retains the same functional site as zebrafish. (A) Schematic representation of MYB mRNA
through evolution and location of putative miR-150 target sites. (B) Sequences and function of the different sites through evolution; numbers
correspond to the positions of the sites on the respective 3’UTRs (nt1 = first nt downstream from the stop codon). The following sequences
were used for this work: Gallus gallus, NM_205306.1; Homo sapiens, NM_001130172.1; Mus musculus, NM_010848.3; Bos taurus, NM_175050.1; Sus
scrofa, XM_001928929.1; Danio rerio, BC059803.1; Xenopus tropicalis, BC16576.1; Oryzias latipes, NM_001104689.1.
Guillon-Munos et al. BMC Molecular Biology 2010, 11:67
http://www.biomedcentral.com/1471-2199/11/67
Page 7 of 11chicken and zebrafish were found to be strongly con-
served throughout evolution, from frogs to humans
(Additional file 3), but were not sufficient for compen-
satory pairing [62]. We identified no functional role for
target sites 3 and 4 in chicken MYB, whereas gga-miR-
150 targeted and repressed MYB mt3 or mt4 reporter
constructs but not MYB mt2 reporter construct. The
mutation of target site 2 completely abolished the
repressor effect of gga-miR-150, as observed with the
mt1234 reporter construct, in which all target sites were
mutated. By contrast, miR-150 acts at sites s3 and s4 in
mice and humans (Fig. 4B)[16,37]. The mutation intro-
duced into target site 3 of the chicken MYB, resulting
in the sequence involved in base pairing to the miR-150
seed sequence being one nucleotide shorter than in
mammals (Fig. 4B, Additional file 3), may account for
the loss of function of this mutant site. This mutation
may also affect the function of conserved site 4, which was
non-functional despite a perfect seed match of 8 nt.
The observed non-functionality of target site 4 suggests
that this site may be functional only in synergy with target
site 3, as observed in mammals [16,37] (Fig. 3 and 4).
Features common to all miR-150/MYB target sites
have been identified in studies of different species: a
perfect seed match of eight to nine nucleotides is
required, with either additional 3’ pairing or synergy
with another closely located site. c-myb is the only
member of the MYB family of transcription factor genes
targeted by miR-150.
Despite the sequence conservation between avian and
mammalian MYB 3’UTRs making it possible to align
these sequences, our observations suggest that the
intrinsic characteristics of the avian MYB 3’UTR result
in avian miR-150 selecting a target site different from its
mammalian orthologs.
The intermediate evolutionary position of chickens in
the vertebrate group may provide insight into the evolu-
tion of MYB/miR-150 target sites. Chicken has retained
the same functional target site as zebrafish and, prob-
ably, frogs. This site appears to be the principal target
site in chicken, despite the presence of the putative
mammalian target sites in the chicken MYB.
Conclusion
Our study of the avian MYB/gga-miR-150 interaction
shows that, despite the involvement of c-myb in devel-
opment and haematopoiesis in a wide range of organ-
isms, from zebrafish to humans, and its regulation
principally through miR-150, the conservation of miR-
150 target site functionality observed between chicken
and zebrafish does not extend to mammals. An addi-
tional set of functional target sites has evolved in mam-
mals, reflecting target site adaptation in these organisms.
Methods
Cell lines
We used three chicken cell lines and one human cell
line: the DF-1 chicken fibroblast cell line, the Marek’s
disease virus-induced lymphoma-derived MSB-1 cell line
and PA9 chicken T cells, the HEK-293FT (293FT)
human cell line. The DF-1 cell line was cultured in
DMEM (Lonza France) supplemented with 10% foetal
bovine serum and 5% chicken serum (Invitrogen-Life
Technologies). The MSB-1 and PA9 cell lines were cul-
tured in RPMI-1640 medium (Lonza France) supple-
mented with 10% foetal bovine serum and 5% chicken
serum. The three cell lines were maintained at 41°C in
an atmosphere containing 5% CO2. The 293FT cell line
(Invitrogen-Life Technologies) is a fast-growing variant
of the HEK-293FT that stably expresses SV40 TAg and
the neomycin resistance gene from pCMVPORT6AT.
neo. 293FT cells were cultured in DMEM supplemented
with 10% foetal bovine serum and were maintained at
37°C in an atmosphere containing 5% CO2.
Plasmid construction
All primer sequences are listed in Additional file 2. The
avian synthetic premiR-150 DNA sequence was obtained
by overlap extension with primers 610 and 611, by poly-
merase chain reaction (PCR). The resulting PCR product
was inserted into the pGEM-T Easy vector (Promega),
digested with KpnIa n dXhoI and inserted into the
pcDNA3 expression vector downstream from the cyto-
megalovirus (CMV) promoter (pmiR-150). A mutated
premiR-150 DNA with a deletion of one cytosine resi-
due from the seed sequence of miR-150 was also con-
structed with primers 612 and 611, using the same
protocol (pmiR-150mut). The 3’ untranslated region
(UTR) fragment (1259 nt from the stop codon) of the
avian MYB cDNA (GenBank accession number
NM_205306.1), which contains four putative miR-150
target sites, was amplified by PCR with primers 682 and
683, using genomic DNA from the thymus of a four-
week-old chicken as the template. The PCR product was
inserted into the NotIs i t eo ft h eRenilla luciferase gene
3’UTR region in a pRL-TK vector (Promega), giving the
MYB wild-type (WT) reporter. We generated MYB
mutant reporters, containing mutations (poly-T or A-
replacing sequences) generating mismatches within the
“seed region” of miR-150, using a PCR-based protocol,
as previously described [65]. Mutations were introduced
into target site 1 directly, via the sequence of primer
806, in a one-step PCR amplification also involving pri-
mer 683. Mutations of target sites 2, 3 and 4 were intro-
duced by overlap extension, using primer pairs 697/698,
699/700, 701/702 (Additional file 2), respectively, in an
initial amplification step, followed by a second step with
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Page 8 of 11primers 682 and 683 (Additional file 2). All intermediate
and final constructs were checked by sequencing with
appropriate primers.
Isolation of lymphoid cells ectopically producing miR-150
or miR-150mut
The stable expression of constructs encoding miR-150
or miR-150mut in PA9 cells was obtained by electro-
poration with the pmiR-150 and pmiR-150mut plasmids,
respectively, using the Amaxa nucleofector device
(Lonza): plasmid (2.5 μg) was added to 2 × 10
6 cells,
with a pcDNA control used in parallel, and cells were
cultured in complete RPMI-1640 medium without selec-
tion for 24 hours. Cells were then selected in complete
RPMI-1640 medium supplemented with 1 mg/ml G418
for three weeks.
Luciferase assay
For the luciferase assay, pcDNAMLuc, carrying the fire-
fly luciferase gene under the control of the CMV pro-
moter, was used for cotransfection, to control for
transfection efficiency.
PA-9 and MSB-1 cells were electroporated with an
Equibio “EasyjecT Plus” electroporator (single pulse, 400
V, 1500 μF) and aluminium electrodes (4-mm cuvette,
Eurogentec). For all assays, 5 × 10
6 cells were electropo-
rated in the presence of 40 μg of pRL-TK_MYBWT and
500 ng of pcDNAMLuc in serum-free RPMI 1640 med-
ium. After electroporation, cells were plated in 6-well
plates, each well containing 2.5 ml of RPMI-1640 med-
ium supplemented with serum, and cultured for 24
hours at 41°C.
DF-1 and 293FT cells were seeded in 96-well plates
(2.5 × 10
4 cells per well). They were cultured for 24
hours before cotransfection with reporter plasmids (100
ng of pRL-TK_MYBWT or mutated and 1.25 ng of
pcDNAMLuc) and 300 ng of effector plasmids (pmiR-
150 or pmiR-150mut or pcDNA control), using Lipofec-
tamine 2000 (Invitrogen-Life technologies) according to
the manufacturer’s protocol.
Luciferase assays were performed 24 hours after trans-
fection, with the Dual-Luciferase Reporter assay system
(Promega). Renilla luciferase activity was normalised
with respect to firefly luciferase activity. Each transfection
reaction was repeated in triplicate for each set of condi-
tions and the experiment was carried out at least three
times. Mean relative luciferase activity is presented. The
significance of differences between effector and reporter
constructs was assessed with Student’s t-test. We consid-
ered P values < 0.05 to be statistically significant.
Northern blotting
Total RNA was extracted from 5 × 10
6 cells with Trizol
reagent (Invitrogen-Life Technologies), according to the
manufacturer’s protocol. Briefly, 15 μg of RNA was sub-
jected to electrophoresis in a 15% acrylamide gel and
transferred onto a nylon membrane (Macherey-Nagel
Porablot Nylon Activated). The membrane was cross-
linked by exposure to UV light (Stratalinker, Stratagene).
The membrane was prehybridised for 1 h and then
hybridised overnight in Perfect Hyb TM Plus hybridisa-
tion buffer (Sigma), at 50°C, with a 20 nM
32P-5’ end-
labelled DNA oligonucleotide probe complementary to
the miRNA, and then washed in low-stringency wash
buffer. Blots were analysed by phosphorimaging with a
Storm 840 (Amersham).
Sequence analyses and target prediction
The online target prediction algorithm Targetscan [66]
http://www.targetscan.org was used to list potential
miR-150 target sites from mammalian, frog and chicken
MYB 3’UTRs. Additional Blast analysis of the miR-150
sequence against the MYB 3’UTR sequence of each spe-
cies analysed was carried out with the accessory applica-
tion “local blast” available in BioEdit version 7.0.5
sequence alignment software.
Additional material
Additional file 1: Hairpin structures of threedifferent mammalian
pre-miR-150 sequences and of the synthetic Gallus gallus pre-miR-
150. The mature miR-150 is shown in italics and the seed sequence is
shown in red.
Additional file 2: Table of primer sequences.
Additional file 3: Predicted binding structures for miR-150 and the
four putative target sites (s1, s2, s3, s4) from different species,
through evolution. The seed sequence (nt2 to nt8) of miR-150 is shown
in red, bold. The seed sequence nucleotides involved in pairing are
underlined; nucleotides involved in pairing outside the seed sequence
are shown in blue, bold. The target sites nucleotides involved in pairing
are shown in bold.
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